Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.

Amwill Health Care Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 544353
₹44.49
▲ 0.49 (1.11%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
—/100
Weak
Valuation
—/100
Data unavailable
Momentum
58/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹7 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
12.39
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 3 met
  • No Quality score is Strong (70 or more)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Value and momentum

2 of 3 met
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • Yes Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.1%
Low 42.5500 · High 44.4900
1W return
0.0%
Low 42.5500 · High 44.4900
1M return
1.8%
Low 41.5000 · High 46.0000
52W return
Data unavailable.
Low 41.5000 · High 46.0000
Lifetime High ₹44.5500 (Sept. 22, 2026)
Lifetime Low ₹41.5000 (Aug. 7, 2026)

Full price history and technicals →

EMA & SMA

Bullish3
Bearish0
5D
43.9
10D
43.6
20D
43.4

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
96.5%
Month avg. delivery
91.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

43.84
Pivot
First resistance45.14
Second resistance45.78
Third resistance47.08
First support43.20
Second support41.90
Third support41.26
Day RSI58.5
Day MFI67.5
Day MACD—
Day MACD signal—

Beta

1M-0.19
3M-0.06
1Y-0.06
3Y-0.06

Price change analysis

↑ 1.8%
Over 1 Month
LowHigh
41.5046.00
—
Over 3 Months
LowHigh
41.5046.00
—
Over 6 Months
LowHigh
41.5046.00
—
Over 1 Year
LowHigh
41.5046.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Ranks #None of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Mar 2026
  • Promoter70.65%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 70.65% in Mar 2026 qtr

Historical fii holding

All shareholding details →

DateClientDealActionQuantityPriceExchange
21 Aug 2026 GLOBALWORTH SECURITIES LIMITED Bulk Sell 100,800 43.2600 BSE
30 Jun 2025 SHILPA AMIT GHARLUTE Bulk Buy 105,600 72.8900 BSE
13 May 2025 AFFLUENCE MARKETING AND DISTRIBUTION PRIVATE LIMITED Bulk Sell 20,400 86.6200 BSE
13 May 2025 AFFLUENCE MARKETING AND DISTRIBUTION PRIVATE LIMITED Bulk Buy 104,400 90.8100 BSE
28 Apr 2025 AFFLUENCE MARKETING AND DISTRIBUTION PRIVATE LIMITED Bulk Buy 85,200 97.6400 BSE
28 Apr 2025 AFFLUENCE MARKETING AND DISTRIBUTION PRIVATE LIMITED Bulk Sell 133,200 95.8300 BSE
23 Apr 2025 FEONA KETAN SHAH Bulk Buy 139,200 82.4600 BSE
21 Apr 2025 ROLY YOGENDRA KAUSHIK Bulk Sell 3,600 82.2400 BSE
21 Apr 2025 ROLY YOGENDRA KAUSHIK Bulk Buy 124,800 82.6200 BSE
16 Apr 2025 PANKAJ DHANJI CHHEDA HUF Bulk Sell 178,800 79.9900 BSE

All bulk and block deals →

Corporate Announcements

All 2 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Insider Trading / SAST Amwill Health Care Ltd - 544353 - Closure of Trading Window
25 Sep 2026 Company Update Amwill Health Care Ltd - 544353 - Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation, 2015

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Amwill Health Care Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.